A Phase 3b, Multicenter, Open-Label, Single-Arm Study of Acalabrutinib (ACP-196) in Subjects with Chronic Lymphocytic Leukaemia

Project: Research

Project Description

NMA HREC Reference Number: HREC/19/CALHN/384
NMA SSA Reference Number: SSA/57485/MonH-2019-186227(v1)
Monash Health Ref: RES-19-0000-662X
StatusActive
Effective start/end date10/10/199/10/24

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • leukaemia